https://orcid.org/0000-0002-7241-7476
Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Steve Freedman, Enrique de-Madaria, Eric Bruckert, Matthias Löhr, Vinciane Rebours & Ravi Jandhyala. (2023) Observed consensus on research priorities for the hypertriglyceridemia patient registry. Current Medical Research and Opinion 0:0, pages 1-7.
Read now
Read now
Ravi Jandhyala. (2023) Development of a definition for real-world evidence using the Jandhyala method for observing consensus opinion among medical affairs pharmaceutical physicians. Current Medical Research and Opinion 0:0, pages 1-8.
Read now
Read now
Ravi Jandhyala. (2023) Commercial impact of adding real-world evidence to clinical trials at regulatory approval: a Markovian-like transition model. Current Medical Research and Opinion 0:0, pages 1-8.
Read now
Read now
Ravi Jandhyala & Raj Rout. (2023) Observing expert opinion of medical affairs pharmaceutical physicians on the value of their clinical experience to the pharmaceutical industry using the Jandhyala method. Current Medical Research and Opinion 0:0, pages 1-10.
Read now
Read now
Ravi Jandhyala. (2022) The effect of adding real-world evidence to regulatory submissions on the breadth of population indicated for rare disease medicine treatment by the European Medicines Agency. Journal of Pharmaceutical Policy and Practice 15:1.
Read now
Read now
Articles from other publishers (6)
Ravi Jandhyala. (2023) Neutral theory: applicability and neutrality of clinical study endpoints where a disease-specific instrument is available. BMC Medical Research Methodology 23:1.
Crossref
Crossref
Ravi Jandhyala. (2022) Concordance between the schedule for the evaluation of individual quality of life-direct weighting (SEIQoL-DW) and the EuroQoL-5D (EQ-5D) measures of quality of life outcomes in adults with X-linked hypophosphatemia. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
Ravi Jandhyala. (2022) Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical Physicians. Frontiers in Pharmacology 13.
Crossref
Crossref
Ravi Jandhyala. (2022) Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) Instrument. Pharmaceutical Medicine 36:1, pages 47-57.
Crossref
Crossref
Ravi Jandhyala. (2022) Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry. F1000Research 11, pages 813.
Crossref
Crossref
Ravi Jandhyala. (2022) Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry. F1000Research 11, pages 813.
Crossref
Crossref